CelLynx Group, Inc.

CIK:0001067286|SEC Filings

Condensed Consolidated Statement of Operations (USD $)	3 Months Ended		6 Months Ended
Condensed Consolidated Statement of Operations (USD $)	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Income Statement [Abstract]
Sales
Cost of Sales
Selling general and administrative expenses:
Amortization and depreciation	638	3,732	1,015	4,571
Bank charges and interest	88,179	51,291	112,635	92,131
Research & development	39,000		78,000
General and administrative expenses	154,988	214,377	268,201	368,667
Total operating expenses	282,804	269,400	459,851	465,369
(Loss) from operations	(282,804)	(269,400)	(459,851)	(465,369)
Other income (expense):
Change in fair value of derivative liability	(2,115,823)	(5,621,028)	(992,832)	(5,595,012)
Change in fair value of accrued warrant and option liability	8,170		8,217	2,718
Gain on settlement of debt	52,240	3,766	52,240	3,766
Amortization of debt discount	(21,258)		(61,867)
Gain on sale of intangible assets		1,482,563		1,485,513
Total Other income (expense)	(2,076,671)	(4,134,699)	(994,242)	(4,103,015)
Net loss	(2,359,475)	(4,404,099)	(1,454,094)	(4,568,384)
Basic (loss) per common share	$ (0.0015)	$ (0.02)	$ (0.0010)	$ (0.02)
Weighted average number of shares outstanding	1,561,498,081	211,946,779	1,521,629,229	267,598,489
Other comprehensive income
Unrealized gain on investment	180,000		270,000
Other comprehensive income	180,000		270,000
Comprehensive (loss)	$ (2,179,475)	$ (4,404,099)	$ (1,184,094)	$ (4,568,384)

Condensed Consolidated Statement of Cash Flows (USD $)	6 Months Ended
Condensed Consolidated Statement of Cash Flows (USD $)	Mar. 31, 2013	Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,454,094)	$ (4,568,384)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,015	4,571
Stock based compensation		79,618
Note payable issued for services		50,000
Change in fair value of derivative liability	992,832	5,595,012
Change in debt discount on convertible notes	61,867	92,131
Change in fair value of accrued warrant and option liability	(4,696)	(2,718)
Change in line of credit for services	90,000
Gain on sale of intangibles		(1,485,513)
Gain on settlement of debt	(52,240)	(3,766)
Changes in operating assets and liabilities:
Change in other assets		20,090
Change in accounts payable and accrued expenses	220,891	119,921
Change in unpaid interest and penalties on notes payable	117,433	76,774
Net cash from (used in) operating activities	(26,992)	(99,038)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes		15,000
Proceeds from convertible line of credit	27,290	87,106
Net cash provided by financing activities	27,290	102,106
NET INCREASE IN CASH	298	3,068
CASH, BEGINNING OF PERIOD	(284)	178
CASH, END OF PERIOD	14	3,246
Supplementary disclosure of Cash Flow Information
Cash paid for interest
NON-CASH INVESTING AND FINANCING ACTIVITIES
Conversion of notes payable to common stock	$ 14,400	$ 52,700

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:
Cash	$ 14	$ (284)
TOTAL CURRENT ASSETS	14	(284)
EQUIPMENT, net	608	1,359
INTANGIBLE ASSETS, net	48,474	48,737
TOTAL ASSETS	49,096	49,812
CURRENT LIABILITIES:
Accounts payable and accrued expenses	2,104,620	1,890,211
Accrued interest	164,672	69,346
Accrued derivative liabilities	2,420,225	1,487,568
Line of credit	765,724	580,473
Promissory notes	397,956	390,488
TOTAL CURRENT LIABILITIES	5,853,197	4,418,086
TOTAL LIABILITIES	5,853,197	4,418,086
STOCKHOLDERS' DEFICIT:
Series A preferred stock, $0.001 par value; 100,000,000 shares authorized; nil shares issued and outstanding
Common stock, $0.001 par value, 2,000,000,000 shares authorized; 1,601,498,001 and 1,457,498,001 shares issued and outstanding as of March 31, 2013 and September 30, 2012 respectively.	1,601,497	1,457,498
Additional paid-in capital	13,044,849	13,170,581
Accumulated deficit	(18,650,447)	(17,196,353)
Treasury stock	(720,000)	(450,000)
Accumulated other comprehensive income	(1,080,000)	(1,350,000)
Total stockholders' deficit	(5,804,101)	(4,368,274)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 49,096	$ 49,812